IRIS
DENTICO, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.522
EU - Europa 335
AS - Asia 165
OC - Oceania 3
SA - Sud America 1
Totale 2.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.522
SE - Svezia 138
CN - Cina 112
UA - Ucraina 66
DE - Germania 42
SG - Singapore 41
FI - Finlandia 36
GB - Regno Unito 22
BE - Belgio 14
FR - Francia 5
IE - Irlanda 4
IN - India 4
IT - Italia 4
IR - Iran 3
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
HK - Hong Kong 1
IL - Israele 1
MN - Mongolia 1
NL - Olanda 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.026
Salva come PNG Salva come JPEG
Città #
Woodbridge 193
Fairfield 177
Chandler 147
Jacksonville 143
Nyköping 121
Houston 101
Ann Arbor 95
Ashburn 67
Seattle 65
Wilmington 58
Cambridge 57
Lawrence 34
Roxbury 34
Singapore 32
Nanjing 31
Beijing 25
Boardman 25
Des Moines 24
Inglewood 23
Princeton 17
New York 16
Brussels 14
Shenyang 14
Jiaxing 12
Brooklyn 10
Santa Clara 10
Hebei 8
San Diego 7
Nanchang 6
Bari 4
Changsha 4
Dublin 4
Ardabil 3
San Mateo 3
Auburn Hills 2
Augusta 2
Dearborn 2
London 2
Marseille 2
Mumbai 2
Paris 2
Washington 2
Auckland 1
Basingstoke 1
Cordoba 1
Dubai 1
Helsinki 1
Hong Kong 1
Islington 1
Kunshan 1
Leawood 1
Los Angeles 1
Monmouth Junction 1
Ningbo 1
Panvel 1
Perth 1
Redwood City 1
Saint Petersburg 1
Tel Aviv 1
Tianjin 1
Ulan Bator 1
Wellington 1
Wuhan 1
Zhengzhou 1
Zuoquan 1
Zurich 1
Totale 1.624
Salva come PNG Salva come JPEG
Nome #
Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years 117
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 101
A search for antibodies to HHV-8 in hemodialysis patients from South-Eastern Italy argues against HHV-8 spread in hemodialysis units 99
Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients 91
Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres 91
Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection 81
Helicobacter pylori seroprevalence in selected groups of albanian volunteers 79
Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults 78
MxA and PKR expression in chronic hepatitis C 76
Immunogenicity and reactogenicity following primary immunisation with a combined DTaP-HBV vaccine and haemophilus influenzae type B vaccine administered by separate or mixed injection 73
Reccomendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 71
SCCA Antigen combined with alpha-fetoprotein as serologic markers of HCC 70
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes 60
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04 60
null 60
Evaluation of hepatitis C virus serotypes and IgM anti-HCV antibodies in two groups of anti-HCV infected subjects from a geographical area in Southeast Italy 57
Long-ter immunogenicity of inactivated Hepatitis A vaccine in healthy adults and children 55
Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors 54
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy 51
Surveillance of toxoplasmosis in pregnant women in Albania 51
Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV single injection of a hexavalent combination or as two separate injections at 3, 6 and 11 months of age 49
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy 49
Molecular characterization of HCV genotype 4 isolates circulating in Italy 43
Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis 43
Diagnostic value of HCV markers in haemodialysis patients 43
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin 42
Hepatitis C Virus Serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southest Italy 40
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients 38
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 37
Safety, tolerability, and immunogenicity of a two -dose regimen of high-titer varicella vaccine in subjects > or =13 years of age 30
Reactogenicity and immunogenicity of a new combined measles-mums-rubella vaccine: results of a multicentre trial 29
Prevalence and risk factors for viral hepatitis in the Kosovarian population: implicationms for health policy 28
Toxoplasmosis in Kosovo pregnant women 26
Seroprevalence of HIV, SSV-2, and Treponema pallidum in the Kosovarian population 25
Viral hepatitis, HIV, human herpes virus and Treponema pallidum infection in haemodialysis patients from Kosovo, 2005 22
Intestinal parasites in healthy subjects in Albania 21
Totale 2.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020291 0 0 0 0 49 27 52 31 53 25 43 11
2020/2021252 32 9 29 16 26 4 26 9 27 37 27 10
2021/2022218 8 21 0 22 11 10 8 12 15 10 60 41
2022/2023448 63 67 28 30 44 66 2 45 85 1 8 9
2023/2024128 18 23 4 38 12 20 0 1 0 1 0 11
2024/202572 4 6 50 8 4 0 0 0 0 0 0 0
Totale 2.040